Physician profile
Roy Miler
NPI 1992071161
$2,282.32
in general payments reported to CMS, 2019-2025
19 companies · $448 in 2025
The $448 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $664 · 2020: $95.93 · 2021: $101 · 2022: $250 · 2023: $349 · 2024: $375 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,171.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $475.89 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $301.86 | 2020-2025 | |
| W. L. Gore & Associates, INC. | $269.07 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic Vascular, INC. | $245.37 | 2019 | |
| Janssen Pharmaceuticals, INC | $208.71 | 2019 | |
| Penumbra, INC. | $184.96 | 2019-2025 | Indigo System |
| Medtronic, INC. | $165.64 | 2022-2025 | Hawkone |
| Inari Medical, INC. | $99.31 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cordis US Corp. | $61.74 | 2022-2023 | Saber |
| Asahi Intecc USA, INC. | $49.45 | 2024 | Peripheral Vascular |
| Abbott Laboratories | $40.80 | 2023-2024 | Perclose Proglide, Jeti |
| Novo Nordisk INC | $40.11 | 2022 | |
| Boston Scientific Corporation | $37.05 | 2021-2025 | Ranger |
| Shockwave Medical, INC | $20.19 | 2021 | |
| Bardy Diagnostics, INC. | $20.00 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.33 | 2025 | |
| Becton, Dickinson and Company | $17.84 | 2024 | Rotarexs 6 F X 135 Cm |
| Bard Peripheral Vascular, INC. | $14.87 | 2022 | |
| Pfizer INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Miler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.